Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Bacterial and fungal cellular proteins and enzymes" is not a specific molecular target but rather a broad category encompassing all proteins and enzymes present in bacterial and fungal cells. This includes functionally and structurally diverse families such as hydrolases (e.g., proteases, lipases, cellulases), oxidoreductases, transferases, lyases, isomerases, ligases, and translocases. These molecules mediate central biological processes including metabolism, signal transduction, cell wall synthesis, and defense responses[2][3][4][1]. Many therapeutic drugs (like antibiotics and antifungals) target particular bacterial or fungal enzymes—for example, inhibiting cell wall biosynthesis enzymes with β-lactams or blocking ergosterol synthesis in fungi. However, “bacterial and fungal cellular proteins and enzymes” is not a single entity or canonical target but an aggregate description for numerous possible drug targets with distinct functions, classifications, and roles in disease[2][3][4][1]. This term is too broad and nonspecific for most applications requiring a well-defined therapeutic target. In structured information frameworks, it should be replaced by specific protein or enzyme names (e.g., "Peptidoglycan D,D-transpeptidase", "Fungal β-1,3-glucan synthase", "Serine protease", "Bacterial DNA gyrase")[2][3][1]. --- **Explanation and notes:** - The provided target is overly broad, not a canonical molecular target, and contains too much information (encompasses thousands of different proteins and enzymes rather than a specific protein, family, or enzyme system). - For structure, specificity, and utility, individual names (e.g., "Fungal serine protease") should be used when possible. - Any biomarkers, drugs, and mechanisms listed above are generic for the class and not for a single target. - Use of this broad label could lead to lack of specificity in research, drug development, and communication.
Inhibition of cell wall synthesis; Inhibition of protein synthesis; Enzyme inhibition; Disruption of cell membrane integrity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal cellular protein and enzyme.